KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Times Interest Earned (2018 - 2020)

Xenon Pharmaceuticals (XENE) has disclosed Times Interest Earned for 4 consecutive years, with -$4.19 as the latest value for Q2 2020.

  • On a quarterly basis, Times Interest Earned rose 85.43% to -$4.19 in Q2 2020 year-over-year; TTM through Mar 2021 was -$255.37, a 2810.62% decrease, with the full-year FY2020 number at -$64.67, down 725.3% from a year prior.
  • Times Interest Earned was -$4.19 for Q2 2020 at Xenon Pharmaceuticals, up from -$24.34 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $52.72 in Q4 2019 to a low of -$49.09 in Q1 2018.
  • A 3-year average of -$15.35 and a median of -$24.34 in 2020 define the central range for Times Interest Earned.
  • Biggest YoY gain for Times Interest Earned was 85.43% in 2020; the steepest drop was 25.88% in 2020.
  • Xenon Pharmaceuticals' Times Interest Earned stood at -$20.92 in 2018, then skyrocketed by 351.95% to $52.72 in 2019, then tumbled by 107.96% to -$4.19 in 2020.
  • Per Business Quant, the three most recent readings for XENE's Times Interest Earned are -$4.19 (Q2 2020), -$24.34 (Q1 2020), and $52.72 (Q4 2019).